Antibody Drug Conjugate company developing a pipeline of monotherapies for targets and/or with payloads
Pheon Therapeutics has raised €71M across 1 funding round from 4 investors, most recently a Series A round in Sep 2022. Based in London, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-28 | Series A | €71M |
| Atlas Venture,Brandon Capital,Forbion,Research Corporation Technologies |
| View deal → |
